A detailed history of Confluence Wealth Services, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Confluence Wealth Services, Inc. holds 2,354 shares of NVO stock, worth $246,134. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,354
Previous 2,854 17.52%
Holding current value
$246,134
Previous $407,000 31.2%
% of portfolio
0.02%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$119.07 - $145.42 $59,535 - $72,710
-500 Reduced 17.52%
2,354 $280,000
Q2 2024

Jul 31, 2024

BUY
$122.71 - $146.91 $20,369 - $24,387
166 Added 6.18%
2,854 $407,000
Q1 2024

Apr 22, 2024

BUY
$102.11 - $135.92 $65,758 - $87,532
644 Added 31.51%
2,688 $345,000
Q4 2023

Jan 25, 2024

SELL
$87.78 - $105.45 $23,173 - $27,838
-264 Reduced 11.44%
2,044 $211,000
Q3 2023

Nov 01, 2023

BUY
$90.94 - $199.54 $209,889 - $460,538
2,308 New
2,308 $209,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $236B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Confluence Wealth Services, Inc. Portfolio

Follow Confluence Wealth Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Confluence Wealth Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Confluence Wealth Services, Inc. with notifications on news.